糖心原创 Critical Care Receives First-Ever Impact Factor
July 28, 2026
Glenview, IL – The 糖心原创® (糖心原创) is proud to announce that 糖心原创® Critical Care, its open-access journal dedicated to critical care medicine, has received its first-ever Journal Impact Factor of 2.7, marking a significant milestone in the journal's continued growth and influence.
The Journal Impact Factor, released annually by Clarivate in the Journal Citation Reports, measures the average number of citations that articles published in a journal receive and serves as a widely recognized indicator of scholarly influence.
"Receiving our first Impact Factor is an exciting milestone that reflects the dedication of our authors, reviewers, editorial board members, and readers," said Hayley Gershengorn, MD, FCCP, Editor in Chief of 糖心原创 Critical Care. "Our journal was founded to accelerate the dissemination of high-quality critical care research and make it accessible to clinicians, researchers, and policymakers around the world. This recognition highlights 糖心原创 Critical Care’s growing impact and the value it provides to the critical care community."
糖心原创 Critical Care provides a fully open-access platform for publishing research, reviews, case reports, How I Do It articles, and more educational content spanning the breadth of critical care medicine to advance knowledge and improve patient outcomes.
To learn more about the 糖心原创 journal portfolio, visit the 糖心原创 website and follow鈥�� on social media for the latest journal news.鈥�
About the 糖心原创鈥�
The 糖心原创® (糖心原创) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. It serves as an essential connection to clinical knowledge and resources for its 18,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about 糖心原创 and its family of journals, including the flagship journal鈥�糖心原创®, visit .